| Nov 13 |
Q3 2024 Eton Pharmaceuticals Inc Earnings Call
|
| Nov 13 |
Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...
|
| Nov 13 |
Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
Eton Pharmaceuticals GAAP EPS of $0.02 beats by $0.03, revenue of $10.3M beats by $0.6M
|
| Nov 12 |
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 7 |
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
|
| Oct 29 |
Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum
|
| Oct 14 |
Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long
|
| Oct 3 |
Eton Pharmaceuticals to buy Increlex product from Ipsen
|
